Trandolapril
SIGMA/T4827 - ≥98% (HPLC), white, powder
Synonym: (2S,3aR,7aS)
CAS Number: 87679-37-6
Empirical Formula (Hill Notation): C24H34N2O5
Molecular Weight: 430.54
MDL Number: MFCD00865776
Linear Formula: C24H34N2O5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | powder |
| InChI | 1S/C24H34N2O5/c1-3-31-24( |
| InChI key | VXFJYXUZANRPDJ-WTNASJBWSA |
| originator | Abbott |
| Quality Level | 100 ![]() |
| SMILES string | CCOC(=O)[C@H](CCc1ccccc1) |
| solubility | DMSO: ≥20 mg/mL |
| Application: | Trandolapril has been used as an angiotensin-converting enzyme (ACE) inhibitor to study its effects on responsiveness of human retinal endothelial cells (HRECs) to vascular endothelial growth factor (VEGF). |
| Biochem/physiol Actions: | Studies have reported that trandolapril inhibits atherosclerosis1 and decreases the occurrence of atrial fibrillation2. |
| Biochem/physiol Actions: | Trandolapril is an ACE inhibitor. |
| Biochem/physiol Actions: | Trandolapril is an ACE inhibitor. Trandolapril differs from other ACE inhibitors in that it has a longer biological half-life and a high degree of lipophilicity. |
| Features and Benefits: | This compound was developed by Abbott . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| Preparation Note: | Trandolapril is soluble in DMSO at a concentration that is greater than or equal to 20 mg/ml. |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H360D |
| Precautionary statements | P201 - P280 - P308 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |


